Navigation Links
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
Date:4/25/2008

ts not included in the above calculation of the diluted weighted average number of shares are shown below:

3 months to March 31, 2008 2007

No. of shares No. of

Millions(1) shares

Millions(1)

Stock options out of the money 12.4 10.3

(1) For the three months ended March 31, 2008 and the three months ended March 31, 2007, certain stock options have been excluded from the calculation of diluted EPS because their exercise prices exceeded Shire plc's average share price during the calculation period.

Unaudited US GAAP results for the three months to March 31, 2008 Selected Notes to the US GAAP Financial Statements (continued)

(2) Analysis of revenues

3 months to March 31, 2008 2007 2008 2008

% % of total

$M $M change revenue

Net product sales:

Specialty Pharmaceuticals ("Specialty")

ADHD

ADDERALL XR 261.5 249.1 5% 37%

VYVANSE 54.4 - - 8%

DAYTRANA 20.3 11.9 71% 3%

336.2 261.0 29% 48%

GI

PENTASA 44.2 43.8 1% 6%

LIALDA / MEZAVANT 27.2 - - 4%

71.4 43.8 63% 10%

Renal

FOSRENOL 36.2 22.8 59% 5%

DYNEPO 6.7 - - 1%


'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
3. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
4. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
5. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
9. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
10. Optherion, Inc. Completes $37 Million Start Up Financing
11. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... Rep. Patrick Kennedy Joins with State Biotech ... Leadership in Research and Development while Boosting ... Industry ,, PROVIDENCE, R.I., Dec. 14 ... prominent leaders in research, medicine and biotechnology ... Facility to discuss the importance of medical ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... of Brookfield Engineering’s Powder Flow Tester – helping Brookfield move ... footprint and more compact design. , ... ... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2
... DOESN,T Keep Them Waiting, WASHINGTON, April 16 ... Capitol Hill to meet with members of,Congress, The Coalition ... ad urging members to keep the best interests of,patients ... workable approval,pathway for safe, effective and affordable biogeneric medicines., ...
... 16 Biotech and pharma,companies are increasingly relying ... Genetic Engineering & Biotechnology News (GEN). The,technique can ... testing drug,candidates for toxic effects, according to an ... http://www.genengnews.com/articles/chitem.aspx?aid=2437 )., "Better screening technologies, noninvasive monitoring, ...
... NORTH VANCOUVER, April 16 /PRNewswire-FirstCall/ - Chromos Molecular,Systems Inc. ... on its on-going restructuring efforts., The Board of ... stepped down as President and Chief Executive Officer, effective,immediately. ... Mr. Duncan, a,founder of the Company, served as President ...
Other Biology Technology:Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story 2Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays 2Chromos provides shareholder update 2
(Date:12/15/2009)... exact an enormous emotional and economic toll on society. ... rip currents each year in U.S. waters and it,s likely ... worldwide. A serious disconnect exists between rip current research ... rip tides and undertows, and more importantly, most people do ... a rip current. , The goal of the Rip Current ...
(Date:12/14/2009)... are part of an international team that has used ... revise the history of North America,s woolly mammoths and ... Earth and Atmospheric Sciences professor Duane Froese and his ... dating of bones and teeth. That analysis concluded that ... America (the ,megafauna,) disappeared about 13,000 years ago. ...
(Date:12/14/2009)... as a clean-burning, renewable fuel that could help wean ... caused by ozone, compared with gasoline, especially in winter, ... , Ozone production from both gasoline and E85, ... percent ethanol, is greater in warm sunny weather than ... because heat and sunlight contribute to ozone formation. But ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 1Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 2Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 3Rabies 3A How to Protect Yourself and Your Pets 51990 1Rabies 3A How to Protect Yourself and Your Pets 51990 2Sanford Rose Associates Opens Minneapolis Office 13075 1Sanford Rose Associates Opens Minneapolis Office 13075 2
... leading study that has implications for the development of ... ovarian cancers that have lost the expression of a ... the loss of the GPC3 gene induces overgrowth through ... cancer growth. , Published today in Developmental Cell, the ...
... May 12, 2008 There exists much ethical controversy brought ... to religion. In a new essay in The Journal of ... medical ethics that draws upon Jewish texts, traditions, and philosophy ... of this faith tradition. , Genetic explanations for how ...
... new project (RevGenUK) is being launched at the John Innes ... , This knowledge can be used to improve the ... grow more sustainably with reduced nitrogen fertilisers. , ... and Biological Sciences Research Council (BBSRC), the project builds on ...
Other Biology News:Religion and the narrative of biological science 2
... Mouse Cytokine Array is a multiplex sandwich ... measurement of 12 cytokines in serum; EDTA, ... Each well of the microplate provided is ... in standards and samples added to the ...
... is designed for the fast and simple ... at any position (for the generation of ... is designed to allow neomycin / kanamycin ... combines a prokaryotic promoter (gb2) for expression ...
... Agencourt AMPure is a magnetic ... requires no sample transfer, centrifugation ... purifies small and large PCR ... 384-well microplates. Agencourt AMPure can ...
Kit includes your choice of reagents for labeling 3 x 10 9 cells and EasySep magnet....
Biology Products: